Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Archimedes Vascular is a medical company that treats patients with hypertension, and provides a delivery catheter system with barostats.
ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.
PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.
Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.
BAKX Therapeutics is a provider of cancer treatment.
Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers.
Powering precision proteomics to enable to the earliest detection of disease.
Avisi Technologies develops nanotechnology-based ophthalmic devices to address vision loss from glaucoma and related eye conditions.
UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.
Senas Medical focuses on innovative cardiac electrophysiology solutions.
Huihe Healthcare specializes in the development of medical devices for structural heart disease.
MAXVAX aims to provide novel vaccine development and commercialization.
Nanovision Technology is a high-tech enterprise focused on high-speed and high-precision radiology.
Brise Pharma operates in the scientific research and technical service industry.
Agile Medical is a surgical robot developer focusing on R&D, industrialization, and precise disease diagnosis and treatment.
Starna Therapeutics developing tissue selective targeted RNA therapies for unmet patient needs.
GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors.
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Changjin Biotechnology specializes in the research and development of edible microbial synthetic proteins for the food sector.
Leto Laboratories is a manufacturer of protein products.
Shenji Bio focuses on the research and development of raw materials such as nucleosides, nucleotides, diagnostic antigens, and antibodies.
Danatlas is a drug research and development company.
New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
Hexaell Biotech is a biopharmaceutical company focused on severe liver disease and cell therapy.
Sherpa Healthcare Partners has invested in 60 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sherpa Healthcare Partners's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Medical Device. The firm invests across 21 different industry categories.
Among tracked funding rounds, GRIT Biotechnology received $84.0M in a Series C round. Sherpa Healthcare Partners's total known invested capital is $1.3B.
Sherpa Healthcare Partners's average investment size is $32.1M across its portfolio of 60 companies.
Recent Sherpa Healthcare Partners portfolio additions include Archimedes Vascular, ZWI Therapeutics, Inc., PAQ Therapeutics, Link Cell Therapies, BAKX Therapeutics. These companies were founded in 2020 or later.